HTX-002(HTX-002) - _专利_临床

概要

基本信息

药物类型

小分子化药

别名-

靶点-

作用机制-

治疗领域

神经系统疾病皮肤和肌肉骨骼疾病

在研适应症-

非在研适应症

拇囊炎术后疼痛

原研机构

Heron Therapeutics, Inc.

在研机构-

非在研机构

Heron Therapeutics, Inc.

最高研发阶段无进展临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

3

项与 HTX-002 相关的临床试验

NCT02762929 / Completed临床2期

A Phase 2, Randomized, Controlled, Multicenter, Evaluation of the Efficacy and Safety of Locally Administered HTX-011, HTX-002, or HTX-009 for Postoperative Analgesia Following Bunionectomy

A Phase 2, Randomized, Controlled, Multicenter, Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

开始日期2016-05-01

申办/合作机构

Heron Therapeutics, Inc.

NCT02689258 / Completed临床2期

A Phase 2, Randomized, Controlled Evaluation of the Efficacy and Safety of HTX-011 or HTX-002 for Post-Operative Analgesia Following Abdominoplasty Surgery

开始日期2016-02-23

申办/合作机构

Heron Therapeutics, Inc.

NCT02504580 / Completed临床2期

A Phase 2, Randomized, Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy